Newcastle Cellular Therapies Facility



Management staff

Dr Mark Jarvis has overall responsibility of Newcastle Cellular Therapies Facility (NCTF), including the haematology stem cell transplant service and clinical trials / ATMP programme. His roles involves strategic, operational, technical and financial management of the NCTF. Mark has a research background in stem cell transplantation and significant business experience in private and public sector roles, including operational management, funding procurement, project management and business development.

Professor James Shaw is Professor of Regenerative Medicine in Diabetes at Newcastle University and Chair of the UK Islet Transplant Consortium, with extensive experience of using clean rooms for allogeneic transplant products.

Dr Erin Hurst is Transplant Programme Director. The Newcastle transplant centre based at the Freeman Hospital performs approximately 180 transplants per year.

Quality and production staff

The Cellular Therapies Facility team also includes Quality Assurance and Quality Control Managers, Production Managers and state-registered clinical scientists. All have experience in either the bio-manufacturing industry or haematopoietic stem cell manipulation for clinical use.

The Facility also has a dedicated Qualified Person (QP) for batch release of products.